Synergistic Therapeutics Obtains US Patent for Sublingual Ketamine Treatment for Depression - P&T Community

Submitted by Anonymous (not verified) on Thu, 04/18/2019 - 14:00

Synergistic Therapeutics Obtains US Patent for Sublingual Ketamine Treatment for Depression  P&T CommunityNAPLES, Fla., April 18, 2019 /PRNewswire/ -- Synergistic Therapeutics LLC has recently announced issuance of a U.S. Patent for a sublingual antidepressant ...